Episode 1306 • • 13:35 - 15:48
1306: Antigenic Drift
Media Ad Buys, Pharmaceutical Profit Models, Vaccine Failure Backstops
A theory is proposed that pharmaceutical companies are shifting toward a recurring revenue model by normalizing the need for annual COVID-19 shots. Additionally, the discussion suggests that the "variant" narrative serves as a convenient explanation or "backstop" for health officials if the initial vaccine rollout fails to prevent infections.